Emilie Picard

Paris, 75006, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Proteomic Signature in Men with Central Serous Chorioretinopathy.

Proteomic Signature in Men with Central Serous Chorioretinopathy.

Journal: Journal of proteome research

Published: February 05, 2026

Long-term exposure of mice to sodium fluoride and to a mixture of endocrine disruptors causes tooth enamel and retina abnormalities associated with changes in hepatic metabolism.

Long-term exposure of mice to sodium fluoride and to a mixture of endocrine disruptors causes tooth enamel and retina abnormalities associated with changes in hepatic metabolism.

Journal: Environment international

Published: May 21, 2025

Metabolomic Signature in Men with Central Serous Chorioretinopathy Using UHPLC-MS.

Metabolomic Signature in Men with Central Serous Chorioretinopathy Using UHPLC-MS.

Journal: Journal of proteome research

Published: May 21, 2025

LRP2 is a potential molecular target for nonsyndromic pathological myopia.

LRP2 is a potential molecular target for nonsyndromic pathological myopia.

Journal: JCI insight

Published: March 04, 2025

Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD).

Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD).

Journal: Cell death & disease

Published: January 17, 2025

Glyburide confers neuroprotection against age-related macular degeneration (AMD).

Glyburide confers neuroprotection against age-related macular degeneration (AMD).

Journal: Translational research : the journal of laboratory and clinical medicine

Published: November 26, 2023

Phototoxicity of low doses of light and influence of the spectral composition on human RPE cells.

Phototoxicity of low doses of light and influence of the spectral composition on human RPE cells.

Journal: Scientific reports

Published: November 07, 2023

In Vitro and In Vivo Safety of Hyaluronic Acid-Decorated Microparticles for Intravitreal Injection of Palmitoylethanolamide, Citicoline, or Glial-Cell-Derived Neurotrophic Factor.

In Vitro and In Vivo Safety of Hyaluronic Acid-Decorated Microparticles for Intravitreal Injection of Palmitoylethanolamide, Citicoline, or Glial-Cell-Derived Neurotrophic Factor.

Journal: Biomacromolecules

Published: August 02, 2023

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.

Journal: International journal of molecular sciences

Published: September 20, 2022

Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models.

Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 31, 2022

Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model.

Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model.

Journal: Pharmaceutics

Published: May 31, 2021

Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.

Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: January 13, 2021

Showing 1-12 of 44

Last Updated: 09/26/2026